Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mastix / Per Os Biosciences is a private label and white label CBD product manufacturer, they produce a gum with astonishing similarities to Hemp4mula - identical blister packs, identical boxes, the gum itself is visually the same, the list of ingredients is 100% identical, they have the same number of pieces per pack (8) and the same level of CBD per piece (10mg). Even the typography on the boxes is identical in placement, size and color - and they both use the slightly unusual term 'gum tablets’ on the packaging. They sell their own-brand product through 'medcbx-dot-com' for $19.99.
The back of the Hemp4mula box states 'Manufactured for and distributed by Kali-Extracts Inc'. If KALI were manufacturing themselves the label would simply read 'Manufactured and distributed by’.
KALY buys its gum from them.
Can only speak for myself, but after quite a few years I think it may be time to cash this one out, just seems to be slowly losing momentum and value.
Made good money, but I was really hoping for some kind of operable device by now - in reality, looks like that is still some way off, if at all.
Respectfully, incorrect.
I have quite few clients who are in exactly this position (I am an industry consultant) - one was processing in excess of 2000 grams of oil a week - who now has been forced to close shop due to the process they were using being unable to meet contaminant levels - and theirs was a closed loop system with vacuum purge - but some systems are profoundly better than others.
And Colorado is not as restrictive as other states - our current butane contaminant levels are 5,000 PPM, whereas in California they have a TOTAL contaminant limit of 400 PPM.
Agree again - there are many ways to skin this particular cat - but quite a few of the methods previously used on a commercial scale have now been rendered unviable due to much lower contaminant limits. Many companies who were extracting in Colorado are now defunct because of this, they simply cannot extract and purify to the current required levels - they have either had to shut shop or invest considerable capital into new extraction systems. Which is why black market extractions are on the rise...
I agree - I'm not saying the KALY process isn't viable - I'm just saying that as there are so many methods available to isolate the THC / CBD / CBN compounds the patent itself is of limited value.
Worth posting again...
In a recent study in The International Journal of Pure and Applied Analytical Chemistry, the scientists had every method available to extract THC / CBD /CBN available to them - from down and dirty methods like CO2, butane, ethanol, olive oil, and sub-zero, right up to advanced methods requiring advanced scientific equipment - ultrasound-assisted extraction, gas chromatography-mass spectrometry, and ion mobility spectrometry etc etc. You know what they chose to use? A $300 espresso machine.
There are literally dozens and dozens of ways of extracting THC / CBD / CBN, which is why the patent is of questionable value - it's what they do with the end product itself that counts - how it is incorporated, marketed and monetized.
In a recent study in The International Journal of Pure and Applied Analytical Chemistry, the scientists had every method available to extract THC / CBD /CBN available to them - from down and dirty methods like CO2, butane, ethanol, olive oil, and sub-zero, right up to advanced methods requiring scientific equipment - ultrasound-assisted extraction, gas chromatography-mass spectrometry, and ion mobility spectrometry etc etc. You know what they chose to use? A $300 espresso machine.
The patent KALY has uses an older methodology and it may well be a solid process, but there are so many other ways of extracting THC / CBD / CBN they render it of limited value. Regardless of the method chosen, I am more interested in what they do with the resulting CBD, the products they put it in and how they monetize the products and bring them to market.
I am involved in this industry and have been heavily invested in ALKM, NOUV and PURA for a long time, and have retained a considerably smaller position in KALY - but KALY's activities over the last few months concern me greatly, so much so I am beginning to have concerns about the group as a whole. The press release this morning for example, is complete extraneous fluff - a classic pump PR.
Despite the food industry’s ever-increasing infatuation with CBD oil, the US Food and Drug Administration (FDA) does not permit CBD to be used in food products or beverages. As of this writing, CBD is considered to be a “drug product” because it is the main ingredient in Epidiolex, an FDA-approved prescription medication that is used to treat seizures in children. Fear of the FDA is partially why the New York City Department of Health has warned restaurants, bakeries and coffee shops in the city that, as of October 1, they’ll be subject to violations and fines if they keep selling CBD-infused foods and drinks.
The FDA has announced that it will hold a public hearing on May 31 to “obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds,” a discussion that presumably will include CBD’s use in food, beverages or dietary supplements.
Patent not enforceable?
Very likely. The patent is a process to extract CBD - it would be very difficult to establish that a particular batch of pure CBD was the end product from a particular process - especially as there are many methods available to extract CBD.
A US Patent Office search yields 1,968 results relating to cannabidiol extraction - and remember, this only lists patents registered in America - there are over 300 CBD/THC extraction patents in China alone.
The top 10 companies most actively patenting in the CBD/CBN/THC extraction arena includes BASF, Dupont, Firmenich, The Wrigley Company, Hercules Powder, Royal Dutch Shell, Arkena, Kuraray, Esso and Givaudan.
CO2 supercritical or sub-critical extraction patents:
Patent #US 8895078 — Inventor Adam Mueller
Patent #US 9044390 — Inventor Gary J. Speier
Patents #US 20060167283 — Inventors Flockhart, Wheatley, Dring, Archer
Patent #US 20150086653 — Inventor GW Pharmaceuticals
Hydrocarbon/butane extraction patents:
Patent #US 9327210 — Inventor Andrew Jones
Patent #US 20040147769 — Inventor John Henry Davis
Guild Extracts holds a granted patent for THCA Isolate
Trichome Technologies has multiple patent applications regarding cannabinoid and terpenoid extraction, isolation and application.
Patent #US 9034395 — GW Pharmaceuticals (GW Pharma) holds a patent for hot gas flow extraction
Looks like Owlstone may get there first...
https://www.dailymail.co.uk/news/article-6549991/Cancer-breathalyser-spot-disease-early-revolutionise-diagnosis.html
They formed another company so they can continue pumping and dumping...
Bought PURA quite some time ago. To be honest - now they are involved with USMJ / NOUV / PJET and especially KALI alarms are going off - may be more of a P&D than I thought.
Do your due diligence.
Mary777 had the corporate address for Marine Services incorrect - according to the FL Div of Corporations it's 1058 N Tamiami Trail, Suite 108 - it's a UPS Store with mailboxes.
Previous registered office was 73 S. Palm Ave, Sarasota - a 300 sq.ft single office rental condo.
Charles Yawn has been involved in many companies, nearly all of which have been Involuntarily Dissolved or Administratively Dissolved - coincidentally, Tucker + Bott were associated with a large number of them in one capacity or another. Aside from Kaly and Marine Services, these are just some of their prior companies out of FL:
304 ISABELLA INC
ACG INTERNATIONAL EQUITY SERVICES, INC
ADJR INVESTMENTS, LLC
ALAN TUCKER FRAMING, INC
ALLIED EQUITY INTERNATIONAL LLC
AMERICAN DREAM MANAGEMENT, INC
BAL HARBOUR MERCHANT SERVICES, INC
BIO-MASS SOUTH INC
CALLI HOLDINGS AND FINANCIAL SOLUTIONS, INC
CAS HOLDINGS AND INVESTMENTS INC
CAS HOLDINGS AND INVESTMENTS LLC
COURTYARDS DEVELOPMENT CORPORATION
DATA INSIGHTS INC
DOWN UNDER ACCESSORIES, INC
EXUMA CAPITOL INC
HOME BEAUTIFICATION SPECIALISTS
III AMIGOS, INC
INNOVATIVE FUNDING SOLUTIONS, INC
INTEGRITY YACHT & MARINE INC
MANAGEMENT CONCEPTS, INC
OCEAN WALK 101, INC
OXFORD INDUSTRIAL GROUP INC
REPROGENETICS, LLC
SIMBIL CONSTRUCTION CORPORATION
SOUTHERN DREAM COMMUNITIES, INC
SOUTHERN RESIDENTIAL AND COMMERCIAL CONSTRUCTION, INC
T. O. B. CELLULAR, INC
THE HUNT OF THOMASVILLE, INC
WESTWIND INVESTMENTS INC.
YACHT AND MARINE HOLDINGS, INC
Originally a textile and apparel company, then a marine services company, now looking to be a player in the MMJ/CBD market - not exactly a natural progression. Last balance sheet I can find is 2012, last SEC filings were back in 2012, recently increased share float to 5 billion(!), erroneous and paid for PR reports, questionable prior pump actions by the principals, dead websites, lack of investor transparency and financial disclosures, dissolutions etc etc.
You may make a few bucks on pumps but essentially the company has itself has nothing to offer - even if the the NCM acquisition is legit the patent is old tech which may well not meet upcoming contaminant level laws.
Again, do your due diligence.
I'm not saying the PURA/NCM initiatives are for nought but what I AM saying is the patent relates to older technology which has already been surpassed, and if the <1000ppm residual restrictions recently placed in Colorado are adopted on a wider scope - then the existing patent may well be of limited benefit, financial or otherwise.
Interestingly, the patent nor the company feature actual levels of residuals post-processing - so we don't know whether they would meet the current CO legislations. All I can say is that MANY current alcohol / ethanol processors cannot meet the prescribed limits and as such are changing their production methods.
I hold substantial PURA stocks, but I bought PURA for their end product, not the technology currently used in isolating the CBD element of the product - which can easily be replaced with other, superior technologies - and which would likely need to be done at increased levels of production anyway.
Respectfully, I'm not bashing or trying to sow doubt - I'm involved in the industry and have been for 10 years since the initial medical legalization in Colorado, and like you, I'm looking for opportunities to make some profits - I'm just doing due diligence as any would investor would / should.
I wish you all the best and hope you make a ton of money, but at the moment there is nothing in this stock that leads me to believe that will be the case.
I'm not here to influence or seek followers, just to make money.
I've done my due diligence, have you?
Facts / Experience / Opinion - which is yours?
This is the first board I have visited which doesn't even seem open to DD.
Old financials, old technology, questionable PR, previous pump and dump by the principals.
The patent is the only thing of value, and again - may well not meet upcoming regulations.
GLTA
My bigger concern would be other states following Colorado's recently established residual extraction contamination levels, which would pretty much negate any benefit from NCMs somewhat outdated patent.
People used alcohol / ethanol extraction because it was cheap for small run commercial processing. New and onerous restrictions and lack of scalability have led to the development of far superior techniques - which are faster and more efficient, can process much higher yields, are way less dangerous, and deliver a superior end product.
As stated, I want everyone to make money, but I'm just not seeing this one.
GLTA.
Well, those posts cleared up nothing - personally, I think any action here is predominantly being driven by the board and questionable PR.
BTW - 'Bitcoins' earlier post is correct - the NCM patent is very much an old-school, labor-intensive process. Also, in February 2018 the state drastically reduced the permissible limits on residual ethanol / alcohol levels used in CBD / THC extraction. Bearing in mind many states follow the processes of marijuana law in Colorado, this is a major concern.
The new levels are VERY difficult to meet, and should the concentrate fail after being tested twice it must be destroyed - which is why most larger scale commercial extractors are now using newer, faster, safer, and more cost effective alternative systems - predominantly CO2 - which produces higher yields and less valuable material is lost.
As an aside, those continuing to use alcohol / ethanol for extraction purposes must have special approvals and regular monitoring from the Fire Department, plus stringent (and costly) fume / fire mitigation systems in place - all of which incur additional costs and further limit its practicality.
My posts aren't intended to rubbish this stock, I want everyone to make money, just can't get my head around this one - and I'm affiliated to the industry.
Not understanding this stock at all...
Originally a textile and apparel company, then a marine services company, now looking to be a player in the MMJ/CBD market. Last balance sheet I can find is 2012, last SEC filings were back in 2012, recently increased share float to 5 billion (!), erroneous PR reports, questionable prior pump actions by the principals, dead websites etc etc.
Only somewhat positive I can find is the acquisition of NCM Biotech and its so so patent - which is a small privately held company with very limited public info - by no stretch of the imagination a 'huge' MJ company, more of a bit player.
What am I missing here?